Dept. of Physiology & Biomedical Engineering, Mayo Clinic College of Medicine, Rochester, MN 55905, USA.
Am J Physiol Regul Integr Comp Physiol. 2010 Mar;298(3):R755-9. doi: 10.1152/ajpregu.00607.2009. Epub 2010 Jan 13.
As our understanding of the importance of individualized medicine continues to grow, the clinical relevance of interindividual variability in hemodynamic variables is receiving increasing attention. However, it is not known whether the rat, which is often used for studies of cardiovascular regulation, exhibits similar interindividual variability. In the present study, we evaluated whether the magnitude of interindividual variability in cardiac output (CO) and total peripheral resistance (TPR) was similar in humans and in rats. We assessed interindividual variability of mean arterial pressure (MAP), CO, and TPR during control conditions in normotensive humans (n = 40) and during normotension and deoxycorticosterone acetate-salt hypertension in Sprague-Dawley rats (n = 16). Humans and rats showed marked interindividual variability in CO and TPR but low variability in MAP. During deoxycorticosterone acetate-salt hypertension, CO was maintained, but TPR was elevated compared with the baseline period. We conclude that the magnitudes of interindividual variability of MAP, CO, and TPR are quantitatively similar in humans and rats, providing support for the relevance of this variability in both species and suggesting that studies in rats could be designed to address questions specific to individualized medicine in hypertension.
随着我们对个体化医学重要性的认识不断加深,血流动力学变量个体间变异性的临床相关性越来越受到关注。然而,目前尚不清楚作为心血管调节研究常用模型的大鼠是否存在类似的个体间变异性。在本研究中,我们评估了大鼠和人类的心脏输出量(CO)和总外周阻力(TPR)个体间变异性的幅度是否相似。我们评估了正常血压的人类(n = 40)和去氧皮质酮醋酸盐-盐高血压的 Sprague-Dawley 大鼠(n = 16)在对照条件下平均动脉压(MAP)、CO 和 TPR 的个体间变异性。人类和大鼠的 CO 和 TPR 个体间变异性显著,但 MAP 的变异性较低。在去氧皮质酮醋酸盐-盐高血压期间,CO 保持不变,但与基线期相比,TPR 升高。我们的结论是,人类和大鼠的 MAP、CO 和 TPR 的个体间变异性幅度在数量上是相似的,这为两种物种的这种变异性的相关性提供了支持,并表明可以设计大鼠研究来解决高血压个体化医学中的具体问题。